1 / 7

Global In-Vitro Colorectal Cancer Screening Tests Market to grow at over 5% CAGR from 2016 to 2023

Get more details @ http://bit.ly/2dDSSX8 <br>Global in-vitro colorectal cancer screening tests market is marked by strategic associations, mergers and acquisitions, and partnerships to expand product range. Major industry players are Alere, Abbott, Eiken Chemical, Siemens Healthcare and Beckman Coulter. Strict government policies challenge new players from entering the industry.

jueekate
Download Presentation

Global In-Vitro Colorectal Cancer Screening Tests Market to grow at over 5% CAGR from 2016 to 2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Immuno-FOB ELISA Test of In-Vitro Colorectal Cancer Screening Tests Market share shows growth of 4% from 2016 to 2023: Global Market Insights Inc. Fuel Cell Market size worth $25.5bn by 2024

  2. Key Insights from In-vitro Colorectal Cancer Screening Tests Market : • Introduction of favorable government initiatives is poised to rise the industry demand over the coming years. Colorectal cancer (CRC) yearly affects over one million women and men and causes more than half a million deaths. • In-Vitro Colorectal Cancer Screening Tests Market size will exceed USD 900 million by 2023; according to a new research report by Global Market Insights, Inc. • UK and Germany in-vitro colorectal cancer screening tests market exhibits high growth due to increasing prevalence of disease. Germany in-vitro colorectal cancer screening tests market share is likely to grow at significant rate by 2023 with increasing government initiatives to improve cancer control with screening quality and healthcare funding.

  3. Continued... • Fecal occult blood (FOBT) testing is the most frequently used method. It is less expensive and has grownup existence in the healthcare industry in contrast to other tests. Methylated gene testing and transferrin assays are the new DNA screening and biomarker tests. • Demand for CRC DNA screening tests may increase at the highest CAGR by 2023, due to increasing R&D expenditure by major industry players in the advanced development. Immuno-FOB stool tests and transferrin assays has shown comparable accuracy owing to easy applicability and is forecast to observe rise in demand over the coming years. • In 2016, nearly 60% - 70% of patients were suffering from CRC at mid or late stage when they were first-time diagnosed, leading to the high death rate. Recently, Cologuard (Exact Sciences) was approved by U.S. FDA and showed high CRC sensitivity (87%) and adenomas (82%).

  4. Continued... • North America, led by U.S. in-vitro colorectal cancer screening tests market was valued at over USD 250 million in 2015. High presence of geriatric population and increasing prevalence of colorectal cancer may drive regional growth. • Asia Pacific, driven by China and Japan, will be the fastest growing in-vitro colorectal cancer screening tests market, on account of increasing number of geriatric population and unhealthy lifestyles leading to cancer. Brazil and Mexico should grow at approximately similar rate with increasing healthcare expenditure. • Global in-vitro colorectal cancer screening tests market is marked by strategic associations, mergers and acquisitions, and partnerships to expand product range. Major industry players are Alere, Abbott, Eiken Chemical, Siemens Healthcare and Beckman Coulter. Strict government policies challenge new players from entering the industry.

  5. Germany In-Vitro Colorectal Cancer Screening Tests Market Size, By Type, 2012-2023 (USD Million)

  6. Browse Full Market Research Report On In-vitro Colorectal Cancer Screening Tests Market @ http://bit.ly/2oodw2i Request for a Sample of this Research Report @ https://www.gminsights.com/request-sample/detail/451https://www.gminsights.com/request-sample/detail/49

  7. Stay In Touch Website: www.gminsights.com Social Media:

More Related